KROS R&D Expenses
Keros Therapeutics Inc · R&D Expenses
KROS R&D Expenses
Latest reported$22.33Mperiod ending
KROS Quarterly R&D Expenses ($4.87M → $22.33M)
Quarterly R&D Expenses
High-resolution chart · PNG
KROS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 22,331,000 | |
| 16,097,000 | |
| 17,912,000 | |
| 19,519,000 | |
| 43,503,000 | |
| 48,709,000 | |
| 45,631,000 | |
| 49,225,000 | |
| 40,515,000 | |
| 38,258,000 | |
| 37,493,000 | |
| 34,140,000 | |
| 32,534,000 | |
| 31,091,000 | |
| 24,867,000 | |
| 21,039,000 | |
| 23,281,000 | |
| 18,078,000 | |
| 18,834,000 | |
| 14,832,000 | |
| 9,983,000 | |
| 11,495,000 | |
| 9,674,000 | |
| 8,395,000 | |
| 7,264,000 | |
| 8,527,000 | |
| 4,161,000 | |
| 3,854,000 | |
| 4,497,000 | |
| 4,867,000 |